CSIRO Livestock Industries Become Reference Site for Denator’s Stabilization Technology
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Denator AB has announced that the Proteomics group at Australia’s CSIRO Livestock Industries has integrated the Stabilizor® T1 system into its proteomic workflow and will act as a reference site for the company’s technology.
Based on the company’s proprietary heat inactivation technology, Stabilizor T1 stabilizes tissue samples from the crucial moment of sampling, permanently eliminating the activity of degradative enzymes, without the use of additives.
As a reference site, the Proteomics group at CSIRO Livestock Industries will gain early access to new products for stabilization of biological samples.
CSIRO Senior Research Scientist Dr Michelle Colgrave explained: “CSIRO conducts a number of proteomics research projects, complementing our genomic efforts to benefit Australia's livestock industry and improve human health. We focus on identifying novel proteins, their functions and post-translational modifications that are associated with commercially important livestock traits and diseases. Our evaluation of this novel stabilization device, Stabilizor T1, has demonstrated its utility in maintaining sample integrity in frozen hypothalamic tissue."
Olof Skold, CEO at Denator, stated: “CSIRO is a well-respected organization and we are delighted that it has demonstrated such confidence in our system. We look forward to continuing working closely with Dr Colgrave and her team in the future.”
Based on the company’s proprietary heat inactivation technology, Stabilizor T1 stabilizes tissue samples from the crucial moment of sampling, permanently eliminating the activity of degradative enzymes, without the use of additives.
As a reference site, the Proteomics group at CSIRO Livestock Industries will gain early access to new products for stabilization of biological samples.
CSIRO Senior Research Scientist Dr Michelle Colgrave explained: “CSIRO conducts a number of proteomics research projects, complementing our genomic efforts to benefit Australia's livestock industry and improve human health. We focus on identifying novel proteins, their functions and post-translational modifications that are associated with commercially important livestock traits and diseases. Our evaluation of this novel stabilization device, Stabilizor T1, has demonstrated its utility in maintaining sample integrity in frozen hypothalamic tissue."
Olof Skold, CEO at Denator, stated: “CSIRO is a well-respected organization and we are delighted that it has demonstrated such confidence in our system. We look forward to continuing working closely with Dr Colgrave and her team in the future.”
